fda compounding glp-1 warning letters october 2025 Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility FDA Warning Letter Breakdown: Sterility

With heart failure, as with all health issues, its best to take preventative action and stop problems from occurring, said Dr

And with Novo Nordisk quietly doubling down on GLP-1 innovation, its hard not to wonder if this study hints at their next move

Hypothalamic dysfunction from paternally imprinted gene deletions is the main pathogenesis of PWS and is characterized by short stature, infantile hypotonia, hypothalamic hypogonadism, excessive appetite, and progressive obesity [1,2]

When you start the medication, these receptors are suddenly flooded with activation signals that were never there before

Obesity, Type 2 Diabetes, and Cancer Risk